Abzena Selects Sartorius Stedim Biotech to Equip Development and Manufacturing Sites in the United States

Abzena plc, the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has selected Sartorius Stedim Biotech as its preferred equipment supplier in the U.S.

Abzena has selected Sartorius Stedim to equip its integrated CDMO facilities in Bristol, PA (development and GMP manufacture of antibody drug conjugates) and San Diego, CA (development and GMP manufacture of monoclonal antibodies and other recombinant proteins).

Sartorius Stedim will provide both facilities with end-to-end process solutions in single-use (SU) format. It will equip Abzena’s San Diego process development laboratory with leading industry technologies such as Ambr250, enabling fast scale up to 500 L initially and later to the 2000 L scale single-use bioreactor for its center of excellence in clinical manufacturing.

“In addition to having selected Sartorius’ industry leading single-use technologies for antibody and ADC production, the Abzena facilities will feature Umetrics process analytics software throughout the process,” said John Burt, chief executive officer Abzena.